跳至主要内容
临床试验/NCT00817557
NCT00817557Unknown4 期

Use of Loteprednol for Contact Lens Intolerance and Dryness

Hom, Milton M., OD, FAAO1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2009年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
25
试验地点
1
主要终点
Wearing time

研究概览

简要总结

Study of the effects of Loteprednol on CL dryness

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Between the ages of 18 and over inclusive.
  • Males or females
  • Any race or ethnic background
  • CL history- experienced intolerance and either switched solutions or lenses without satisfactory relief.
  • Patient is in generally good & stable overall health.
  • Patient likely to comply with study guidelines & study visits.
  • Informed consent signed.
  • OSDI score 18 or higher while wearing lenses
  • Unsatisfactory wearing time with contact lenses

排除标准

  • Corneal refractive surgery within 6 months of this study.
  • Contact lens use on day of examination.
  • Corneal ectasia.
  • Current use of Restasis
  • Intra-ocular surgery within 6 months or ocular laser surgery within 6 months.
  • Pregnant or lactating women.
  • Ocular pathology (includes glaucoma and cataract) which could impact results and/or place patient at risk.

研究组 & 干预措施

Loteprednol

Active Comparator

Loteprednol BID

干预措施: Loteprednol (Drug)

Rewetter

Placebo Comparator

Rewetter BID

干预措施: Rewetter (Other)

结局指标

主要结局

Wearing time

时间窗: 28 days

次要结局

  • OSDI(28 days)

研究者

发起方
Hom, Milton M., OD, FAAO
申办方类型
Indiv

研究点 (1)

Loading locations...

相似试验